Related references
Note: Only part of the references are listed.Research on Early-Stage Carcinogenesis: Are We Approaching Paradigm Instability?
Stuart G. Baker et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
RUNX3 Inactivation in Colorectal Polyps Arising Through Different Pathways of Colonic Carcinogenesis
Manish M. Subramaniam et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats
Stuart G. Baker et al.
BMC CANCER (2009)
A Comparison of Colon and Rectal Somatic DNA Alterations
Martha L. Slattery et al.
DISEASES OF THE COLON & RECTUM (2009)
Identification and Functional Characterization of ERK/MAPK Phosphorylation Sites in the Runx2 Transcription Factor
Chunxi Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Role of transforming growth factor-beta superfamily signaling pathways in human disease
Kelly J. Gordon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer
Gen Sheng Wu
CANCER AND METASTASIS REVIEWS (2007)
So many correlated tests, so little time!: Rapid adjustment of P values for multiple correlated tests
Karen N. Conneely et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Morphogens, morphostats, microarchitecture and malignancy
John D. Potter
NATURE REVIEWS CANCER (2007)
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer
Martha L. Slattery et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The RUNX genes: Gain or loss of function in cancer
K Blyth et al.
NATURE REVIEWS CANCER (2005)
Postgenomic global analysis of translational control induced by oncogenic signaling
VK Rajasekhar et al.
ONCOGENE (2004)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
Role of RUNX family members in transcriptional repression and gene silencing
KL Durst et al.
ONCOGENE (2004)
Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells
E Vial et al.
JOURNAL OF CELL SCIENCE (2003)
Physical activity and colorectal cancer
ML Slattery et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
The Runx genes as dominant oncogenes
ER Cameron et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
RUNX transcription factors as key targets of TGF-β superfamily signaling
Y Ito et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2003)
Energy balance and rectal cancer: An evaluation of energy intake, energy expenditure, and body mass index
ML Slattery et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2003)
Runx transcription factors and the developmental balance between cell proliferation and differentiation
JA Coffman
CELL BIOLOGY INTERNATIONAL (2003)
Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-β and bone morphogenetic protein
KS Lee et al.
ONCOGENE (2002)
Prognostic significance of P53 mutations in colon cancer at the population level
WS Samowitz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The RUNX3 gene -: sequence, structure and regulated expression
C Bangsow et al.
GENE (2001)
Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors
ML Slattery et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
